The DOI matches its Crossref record; 299 of the 299 references it cites were found in a registry or an index.
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
Open accessAbstract
CC chemokines (or β-chemokines) are 28 chemotactic cytokines with an N-terminal CC domain that play an important role in immune system cells, such as CD4+ and CD8+ lymphocytes, dendritic cells, eosinophils, macrophages, monocytes, and NK cells, as well in neoplasia. In this review, we discuss human CC motif chemokine ligands: CCL1, CCL3, CCL4, CCL5, CCL18, CCL19, CCL20, CCL21, CCL25, CCL27, and CCL28 (CC motif chemokine receptor CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 ligands). We present their functioning in human physiology and in neoplasia, including their role in the proliferation, apoptosis resistance, drug resistance, migration, and invasion of cancer cells. We discuss the significance of chemokine receptors in organ-specific metastasis, as well as the influence of each chemokine on the recruitment of various cells to the tumor niche, such as cancer-associated fibroblasts (CAF), Kupffer cells, myeloid-derived suppressor cells (MDSC), osteoclasts, tumor-associated macrophages (TAM), tumor-infiltrating lymphocytes (TIL), and regulatory T cells (Treg). Finally, we show how the effect of the chemokines on vascular endothelial cells and lymphatic endothelial cells leads to angiogenesis and lymphangiogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Fagerberg, L., Hallström, B. M., Oksvold, P., Kampf, C., Djureinovic, D., Odeberg, J., Habuka, M., Tahmasebpoor, S., Danielsson, A., Edlund, K., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.035600 · Cited by 3,665
A pathology atlas of the human cancer transcriptome
Uhlen, M., Zhang, C., Lee, S., Sjöstedt, E., Fagerberg, L., Bidkhori, G., Benfeitas, R., Arif, M., Liu, Z., Edfors, F., et al. (2017) · Science · doi:10.1126/science.aan2507 · Cited by 3,371
Noman, M. Z., Desantis, G., Janji, B., Hasmim, M., Karray, S., Dessen, P., Bronte, V., & Chouaib, S. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131916 · Cited by 2,166
Böttcher, J. P., Bonavita, E., Chakravarty, P., Blees, H., Cabeza-Cabrerizo, M., Sammicheli, S., Rogers, N. C., Sahai, E., Zelenay, S., & Reis e Sousa, C. (2018) · Cell · doi:10.1016/j.cell.2018.01.004 · Cited by 1,857
A guide to chemokines and their receptors
Hughes, C. E., & Nibbs, R. J. B. (2018) · The FEBS Journal · doi:10.1111/febs.14466 · Cited by 1,412
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Facciabene, A., Peng, X., Hagemann, I. S., Balint, K., Barchetti, A., Wang, L.-P., Gimotty, P. A., Gilks, C. B., Lal, P., Zhang, L., et al. (2011) · Nature · doi:10.1038/nature10169 · Cited by 1,376
Gunn, M. D., Tangemann, K., Tam, C., Cyster, J. G., Rosen, S. D., & Williams, L. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.258 · Cited by 1,001
Iellem, A., Mariani, M., Lang, R., Recalde, H., Panina-Bordignon, P., Sinigaglia, F., & D'Ambrosio, D. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.847 · Cited by 914
Dangaj, D., Bruand, M., Grimm, A. J., Ronet, C., Barras, D., Duttagupta, P. A., Lanitis, E., Duraiswamy, J., Tanyi, J. L., Benencia, F., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.05.004 · Cited by 875
Castellino, F., Huang, A. Y., Altan-Bonnet, G., Stoll, S., Scheinecker, C., & Germain, R. N. (2006) · Nature · doi:10.1038/nature04651 · Cited by 855
CCL27–CCR10 interactions regulate T cell–mediated skin inflammation
Homey, B., Alenius, H., Müller, A., Soto, H., Bowman, E. P., Yuan, W., McEvoy, L., Lauerma, A. I., Assmann, T., Bünemann, E., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-157 · Cited by 807
The CC chemokine CCL20 and its receptor CCR6
Schutyser, E., Struyf, S., & Van Damme, J. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00049-2 · Cited by 774
Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor
Neote, K., DiGregorio, D., Mak, J. Y., Horuk, R., & Schall, T. J. (1993) · Cell · doi:10.1016/0092-8674(93)90118-a · Cited by 763
Preferential Migration of Activated CD4 + and CD8 + T Cells in Response to MIP-1α and MIP-1β
Taub, D. D., Conlon, K., Lloyd, A. R., Oppenheim, J. J., & Kelvin, D. J. (1993) · Science · doi:10.1126/science.7682337 · Cited by 730
Macrophage inflammatory protein-1
Menten, P., Wuyts, A., & Van Damme, J. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00045-x · Cited by 706
Kitamura, T., Qian, B.-Z., Soong, D., Cassetta, L., Noy, R., Sugano, G., Kato, Y., Li, J., & Pollard, J. W. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141836 · Cited by 651
The Platelet Lifeline to Cancer: Challenges and Opportunities
Haemmerle, M., Stone, R. L., Menter, D. G., Afshar-Kharghan, V., & Sood, A. K. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.002 · Cited by 638
Ponath, P. D., Qin, S., Post, T. W., Wang, J., Wu, L., Gerard, N. P., Newman, W., Gerard, C., & Mackay, C. R. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2437 · Cited by 612
Cloning, expression, and characterization of the human eosinophil eotaxin receptor.
Daugherty, B. L., Siciliano, S. J., DeMartino, J. A., Malkowitz, L., Sirotina, A., & Springer, M. S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.2349 · Cited by 547
A dendritic-cell-derived C–C chemokine that preferentially attracts naive T cells
Adema, G. J., Hartgers, F., Verstraten, R., de Vries, E., Marland, G., Menon, S., Foster, J., Xu, Y., Nooyen, P., McClanahan, T., et al. (1997) · Nature · doi:10.1038/42716 · Cited by 523
Schall, T. J., Bacon, K., Camp, R. D., Kaspari, J. W., & Goeddel, D. V. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.6.1821 · Cited by 520
Imtiyaz, H. Z., Williams, E. P., Hickey, M. M., Patel, S. A., Durham, A. C., Yuan, L.-J., Hammond, R., Gimotty, P. A., Keith, B., & Simon, M. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39506 · Cited by 461
Tan, M. C. B., Goedegebuure, P. S., Belt, B. A., Flaherty, B., Sankpal, N., Gillanders, W. E., Eberlein, T. J., Hsieh, C.-S., & Linehan, D. C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1746 · Cited by 450
Alpha and β chemokines induce NK cell migration and enhance NK-mediated cytolysis
Taub, D. D., Sayers, T. J., Carter, C. R., & Ortaldo, J. R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.8.3877 · Cited by 449
Chiu, D. K.-C., Tse, A. P.-W., Xu, I. M.-J., Di Cui, J., Lai, R. K.-H., Li, L. L., Koh, H.-Y., Tsang, F. H.-C., Wei, L. L., Wong, C.-M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00530-7 · Cited by 448 · cited 13×
“The most significant is the area affected by chronic hypoxia [9], characterized by the accumulation of tumor-associated macrophages (TAM) [10–13], regulatory T cells (Treg) [14–16], and myeloid-derived suppressor cells (MDSC) [17,18].”
BackgroundInfluentialRaport, C. J., Gosling, J., Schweickart, V. L., Gray, P. W., & Charo, I. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17161 · Cited by 448
Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype
Gabrusiewicz, K., Rodriguez, B., Wei, J., Hashimoto, Y., Healy, L. M., Maiti, S. N., Thomas, G., Zhou, S., Wang, Q., Elakkad, A., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.85841 · Cited by 445
Schlecker, E., Stojanovic, A., Eisen, C., Quack, C., Falk, C. S., Umansky, V., & Cerwenka, A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201018 · Cited by 438
Identification of CCR6, the Specific Receptor for a Novel Lymphocyte-directed CC Chemokine LARC
Baba, M., Imai, T., Nishimura, M., Kakizaki, M., Takagi, S., Hieshima, K., Nomiyama, H., & Yoshie, O. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14893 · Cited by 409
Jayaprakash, P., Ai, M., Liu, A., Budhani, P., Bartkowiak, T., Sheng, J., Ager, C., Nicholas, C., Jaiswal, A. R., Sun, Y., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96268 · Cited by 399
The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells.
Zingoni, A., Soto, H., Hedrick, J. A., Stoppacciaro, A., Storlazzi, C. T., Sinigaglia, F., D’Ambrosio, D., O’Garra, A., Robinson, D. S., Rocchi, M., et al. (1998) · PubMed · Cited by 395
Targeting CCL5 in inflammation
Marques, R. E., Guabiraba, R., Russo, R. C., & Teixeira, M. M. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.837886 · Cited by 384
Baekkevold, E. S., Yamanaka, T., Palframan, R. T., Carlsen, H. S., Reinholt, F. P., von Andrian, U. H., Brandtzaeg, P., & Haraldsen, G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.9.1105 · Cited by 378
Expression of CC Chemokine Receptor-7 and Regional Lymph Node Metastasis of B16 Murine Melanoma
Wiley, H. E., Gonzalez, E. B., Maki, W., Wu, M.-T., & Hwang, S. T. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.21.1638 · Cited by 377
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
Griss, J., Bauer, W., Wagner, C., Simon, M., Chen, M., Grabmeier-Pfistershammer, K., Maurer-Granofszky, M., Roka, F., Penz, T., Bock, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12160-2 · Cited by 369
Chew, V., Chen, J., Lee, D., Loh, E., Lee, J., Lim, K. H., Weber, A., Slankamenac, K., Poon, R. T. P., Yang, H., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300509 · Cited by 359
Cutting Edge: The Chemokine Receptor CCR8 Is Preferentially Expressed in Th2 But Not Th1 Cells
Zingoni, A., Soto, H., Hedrick, J. A., Stoppacciaro, A., Storlazzi, C. T., Sinigaglia, F., D’Ambrosio, D., O’Garra, A., Robinson, D., Rocchi, M., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.547 · Cited by 357
Homey, B., Wang, W., Soto, H., Buchanan, M. E., Wiesenborn, A., Catron, D., Müller, A., McClanahan, T. K., Dieu-Nosjean, M.-C., Orozco, R., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3465 · Cited by 332
Tumor microenvironments direct the recruitment and expansion of human Th17 cells
Su, X., Ye, J., Hsueh, E. C., Zhang, Y., Hoft, D. F., & Peng, G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902813 · Cited by 324
Willimann, K., Legler, D. F., Loetscher, M., Stuber Roos, R., Belen Delgado, M., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199806)28:06<2025::aid-immu2025>3.0.co;2-c · Cited by 306
Abe, M., Hiura, K., Wilde, J., Moriyama, K., Hashimoto, T., Ozaki, S., Wakatsuki, S., Kosaka, M., Kido, S., Inoue, D., et al. (2002) · Blood · doi:10.1182/blood.v100.6.2195 · Cited by 294
Identification of a Novel Chemokine (CCL28), which Binds CCR10 (GPR2)
Wang, W., Soto, H., Oldham, E. R., Buchanan, M. E., Homey, B., Catron, D., Jenkins, N., Copeland, N. G., Gilbert, D. J., Nguyen, N., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001461200 · Cited by 293
Combadiere, C., Ahuja, S. K., Lee Tiffany, H., & Murphy, P. M. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.60.1.147 · Cited by 292
Yang, X., Lu, Y., Hang, J., Zhang, J., Zhang, T., Huo, Y., Liu, J., Lai, S., Luo, D., Wang, L., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0111 · Cited by 277
Development and function of TH17 cells in health and disease
Louten, J., Boniface, K., & de Waal Malefyt, R. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.04.003 · Cited by 266
Huang, R., Wang, S., Wang, N., Zheng, Y., Zhou, J., Yang, B., Wang, X., Zhang, J., Guo, L., Wang, S., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2435-y · Cited by 263
Hieshima, K., Imai, T., Baba, M., Shoudai, K., Ishizuka, K., Nakagawa, T., Tsuruta, J., Takeya, M., Sakaki, Y., Takatsuki, K., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.3.1140 · Cited by 256
Lazarus, N. H., Kunkel, E. J., Johnston, B., Wilson, E., Youngman, K. R., & Butcher, E. C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3799 · Cited by 250
Cloning and Functional Expression of a Human Eosinophil CC Chemokine Receptor
Combadiere, C., Ahuja, S. K., & Murphy, P. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16491 · Cited by 248
Homing and Function of Human Skin γδ T Cells and NK Cells: Relevance for Tumor Surveillance
Ebert, L. M., Meuter, S., & Moser, B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4331 · Cited by 243
Chiu, D. K., Xu, I. M., Lai, R. K., Tse, A. P., Wei, L. L., Koh, H., Li, L. L., Lee, D., Lo, R. C., Wong, C., et al. (2016) · Hepatology · doi:10.1002/hep.28655 · Cited by 241
Chen, K.-J., Lin, S.-Z., Zhou, L., Xie, H.-Y., Zhou, W.-H., Taki-Eldin, A., & Zheng, S.-S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024671 · Cited by 240
Chang, L.-Y., Lin, Y.-C., Mahalingam, J., Huang, C.-T., Chen, T.-W., Kang, C.-W., Peng, H.-M., Chu, Y.-Y., Chiang, J.-M., Dutta, A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2493 · Cited by 232
Choi, S. J., Oba, Y., Gazitt, Y., Alsina, M., Cruz, J., Anderson, J., & Roodman, G. D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13116 · Cited by 231
Liu, C., Yao, Z., Wang, J., Zhang, W., Yang, Y., Zhang, Y., Qu, X., Zhu, Y., Zou, J., Peng, S., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0460-0 · Cited by 230
Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma
Wang, X., Lang, M., Zhao, T., Feng, X., Zheng, C., Huang, C., Hao, J., Dong, J., Luo, L., Li, X., et al. (2017) · Oncogene · doi:10.1038/onc.2016.458 · Cited by 227
Chaturvedi, P., Gilkes, D. M., Takano, N., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406655111 · Cited by 226
Mgrditchian, T., Arakelian, T., Paggetti, J., Noman, M. Z., Viry, E., Moussay, E., Van Moer, K., Kreis, S., Guerin, C., Buart, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703921114 · Cited by 226
Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer
Su, S., Liao, J., Liu, J., Huang, D., He, C., Chen, F., Yang, L., Wu, W., Chen, J., Lin, L., et al. (2017) · Cell Research · doi:10.1038/cr.2017.34 · Cited by 225
Tripathi, C., Tewari, B. N., Kanchan, R. K., Baghel, K. S., Nautiyal, N., Shrivastava, R., Kaur, H., Bhatt, M. L. B., & Bhadauria, S. (2014) · Oncotarget · doi:10.18632/oncotarget.2110 · Cited by 224
Deng, J., Li, J., Sarde, A., Lines, J. L., Lee, Y.-C., Qian, D. C., Pechenick, D. A., Manivanh, R., Le Mercier, I., Lowrey, C. H., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0507 · Cited by 224
A Skin-selective Homing Mechanism for Human Immune Surveillance T Cells
Schaerli, P., Ebert, L., Willimann, K., Blaser, A., Roos, R. S., Loetscher, P., & Moser, B. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032177 · Cited by 218
Liu, J., Chen, S., Wang, W., Ning, B.-F., Chen, F., Shen, W., Ding, J., Chen, W., Xie, W.-F., & Zhang, X. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.05.022 · Cited by 218
Schutyser, E., Struyf, S., Proost, P., Opdenakker, G., Laureys, G., Verhasselt, B., Peperstraete, L., Van de Putte, I., Saccani, A., Allavena, P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112275200 · Cited by 208
Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
Daniel, S. K., Sullivan, K. M., Labadie, K. P., & Pillarisetty, V. G. (2019) · Clinical and Translational Medicine · doi:10.1186/s40169-019-0226-9 · Cited by 207
Secondary Lymphoid Tissue Chemokine Mediates T Cell-Dependent Antitumor Responses In Vivo
Sharma, S., Stolina, M., Luo, J., Strieter, R. M., Burdick, M., Zhu, L. X., Batra, R. K., & Dubinett, S. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4558 · Cited by 203
Tumor-Associated Macrophages in the Cutaneous SCC Microenvironment Are Heterogeneously Activated
Pettersen, J. S., Fuentes-Duculan, J., Suárez-Fariñas, M., Pierson, K. C., Pitts-Kiefer, A., Fan, L., Belkin, D. A., Wang, C. Q. F., Bhuvanendran, S., Johnson-Huang, L. M., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.9 · Cited by 203
Zaballos, A., Gutiérrez, J., Varona, R., Ardavín, C., & Márquez, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.5671 · Cited by 202
Ding, Y., Shimada, Y., Maeda, M., Kawabe, A., Kaganoi, J., Komoto, I., Hashimoto, Y., Miyake, M., Hashida, H., & Imamura, M. (2003) · PubMed · Cited by 199
CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer
Lin, L., Chen, Y.-S., Yao, Y.-D., Chen, J.-Q., Chen, J.-N., Huang, S.-Y., Zeng, Y.-J., Yao, H.-R., Zeng, S.-H., Fu, Y.-S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5325 · Cited by 198
Lee, E., Fertig, E. J., Jin, K., Sukumar, S., Pandey, N. B., & Popel, A. S. (2014) · Nature Communications · doi:10.1038/ncomms5715 · Cited by 197
Das, S., Sarrou, E., Podgrabinska, S., Cassella, M., Mungamuri, S. K., Feirt, N., Gordon, R., Nagi, C. S., Wang, Y., Entenberg, D., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20111627 · Cited by 195
Twist1 Induces CCL2 and Recruits Macrophages to Promote Angiogenesis
Low-Marchelli, J. M., Ardi, V. C., Vizcarra, E. A., van Rooijen, N., Quigley, J. P., & Yang, J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-0653 · Cited by 190
Identification of human CCR8 as a CCL18 receptor
Islam, S. A., Ling, M. F., Leung, J., Shreffler, W. G., & Luster, A. D. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130240 · Cited by 190
Andre, F., Cabioglu, N., Assi, H., Sabourin, J. C., Delaloge, S., Sahin, A., Broglio, K., Spano, J. P., Combadiere, C., Bucana, C., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl053 · Cited by 190
CCR5+ Myeloid-Derived Suppressor Cells Are Enriched and Activated in Melanoma Lesions
Blattner, C., Fleming, V., Weber, R., Himmelhan, B., Altevogt, P., Gebhardt, C., Schulze, T. J., Razon, H., Hawila, E., Wildbaum, G., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-0348 · Cited by 182
Yan, M., Jene, N., Byrne, D., Millar, E. K., O'Toole, S. A., McNeil, C. M., Bates, G. J., Harris, A. L., Banham, A. H., Sutherland, R. L., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2869 · Cited by 180
CCL5 increases lung cancer migration via PI3K, Akt and NF-κB pathways
Huang, C.-Y., Fong, Y.-C., Lee, C.-Y., Chen, M.-Y., Tsai, H.-C., Hsu, H.-C., & Tang, C.-H. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.11.014 · Cited by 176
López-Giral, S., Quintana, N. E., Cabrerizo, M., Alfonso-Pérez, M., Sala-Valdés, M., de Soria, V. G. G., Fernández-Rañada, J. M., Fernández-Ruiz, E., & Muñoz, C. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1203652 · Cited by 176
Wang, S.-C., Hong, J.-H., Hsueh, C., & Chiang, C.-S. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2011.128 · Cited by 174
The Viral Chemokine Macrophage Inflammatory Protein-II Is a Selective Th2 Chemoattractant
Sozzani, S., Luini, W., Bianchi, G., Allavena, P., Wells, T. N. C., Napolitano, M., Bernardini, G., Vecchi, A., D’Ambrosio, D., Mazzeo, D., et al. (1998) · Blood · doi:10.1182/blood.v92.11.4036 · Cited by 168
Immune Evasion by Murine Melanoma Mediated through CC Chemokine Receptor-10
Murakami, T., Cardones, A. R., Finkelstein, S. E., Restifo, N. P., Klaunberg, B. A., Nestle, F. O., Castillo, S. S., Dennis, P. A., & Hwang, S. T. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030593 · Cited by 168
Lança, T., Costa, M. F., Gonçalves-Sousa, N., Rei, M., Grosso, A. R., Penido, C., & Silva-Santos, B. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300434 · Cited by 168
Ban, Y., Mai, J., Li, X., Mitchell-Flack, M., Zhang, T., Zhang, L., Chouchane, L., Ferrari, M., Shen, H., & Ma, X. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2913 · Cited by 166
CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells
Singh, S. K., Mishra, M. K., Eltoum, I.-E. A., Bae, S., Lillard, J. W., & Singh, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-19643-0 · Cited by 165
Amersi, F. F., Terando, A. M., Goto, Y., Scolyer, R. A., Thompson, J. F., Tran, A. N., Faries, M. B., Morton, D. L., & Hoon, D. S. B. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2025 · Cited by 163
Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas
Zeiner, P. S., Preusse, C., Golebiewska, A., Zinke, J., Iriondo, A., Muller, A., Kaoma, T., Filipski, K., Müller‐Eschner, M., Bernatz, S., et al. (2019) · Brain Pathology · doi:10.1111/bpa.12690 · Cited by 162
Vallet, S., Pozzi, S., Patel, K. J., Vaghela, N. N., Fulciniti, M., Veiby, P. O., Hideshima, T., Santo, L., Cirstea, D. D., Scadden, D. T., et al. (2011) · Leukemia · doi:10.1038/leu.2011.43 · Cited by 160
Xu, Z., Zhu, C., Chen, C., Zong, Y., Feng, H., Liu, D., Feng, W., Zhao, J., & Lu, A. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-1010-2 · Cited by 159
Unique Regulation of CCL18 Production by Maturing Dendritic Cells
Vulcano, M., Struyf, S., Scapini, P., Cassatella, M. A., Bernasconi, S., Bonecchi, R., Calleri, A., Penna, G., Adorini, L., Luini, W., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3843 · Cited by 156
Brand, S., Olszak, T., Beigel, F., Diebold, J., Otte, J., Eichhorst, S. T., Göke, B., & Dambacher, J. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20672 · Cited by 156
Wang, S., Liu, S., Sun, H., Huang, T., Chan, C.-H., Yang, C., Yeh, H., Huang, Y., Chou, W., Lin, Y., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu218 · Cited by 156
Oba, Y., Lee, J., Ehrlich, L. A., Chung, H. Y., Jelinek, D. F., Callander, N. S., Horuk, R., Choi, S. J., & Roodman, G. D. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2004.11.015 · Cited by 156
Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3
Schaller, T. H., Batich, K. A., Suryadevara, C. M., Desai, R. R., & Sampson, J. H. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1384313 · Cited by 155
Mondini, M., Loyher, P.-L., Hamon, P., de Thoré, M. G., Laviron, M., Berthelot, K., Clémenson, C., Salomon, B. L., Combadière, C., Deutsch, É., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0633 · Cited by 154
Prediction of lymph node metastasis in colorectal carcinoma by expressionof chemokine receptor CCR7
Günther, K., Leier, J., Henning, G., Dimmler, A. W., Weißbach, R., Hohenberger, W., & Förster, R. (2005) · International Journal of Cancer · doi:10.1002/ijc.21123 · Cited by 153
Hypoxia-induced CCL28 promotes recruitment of regulatory T cells and tumor growth in liver cancer
Ren, L., Yu, Y., Wang, L., Zhu, Z., Lu, R., & Yao, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.12409 · Cited by 149
Kleeff, J. H., Kusama, T., Rossi, D. L., Ishiwata, T., Maruyama, H., Friess, H., Büchler, M. W., Zlotnik, A., & Korc, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990517)81:4<650::aid-ijc23>3.0.co;2-# · Cited by 148
Chen, X.-J., Deng, Y.-R., Wang, Z., Wei, W.-F., Zhou, C.-F., Zhang, Y., Yan, R.-M., Liang, L.-J., Zhong, M., Li, L., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1748-1 · Cited by 145
The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum
Schraufstatter, I. U., Zhao, M., Khaldoyanidi, S. K., & DiScipio, R. G. (2012) · Immunology · doi:10.1111/j.1365-2567.2011.03541.x · Cited by 144
Endres, M. J., Garlisi, C. G., Xiao, H., Shan, L.-X., & Hedrick, J. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.12.1993 · Cited by 143
Maximal T Cell–Mediated Antitumor Responses Rely upon CCR5 Expression in Both CD4+ and CD8+ T Cells
González-Martín, A., Gómez, L., Lustgarten, J., Mira, E., & Mañes, S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1687 · Cited by 142
Tumor immune escape by the loss of homeostatic chemokine expression
Pivarcsi, A., Müller, A., Hippe, A., Rieker, J., Lierop, A. V., Steinhoff, M. S., Seeliger, S., Kubitza, R., Pippirs, U., Meller, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705673104 · Cited by 141
Cloning and Characterization of a Novel Murine β Chemokine Receptor, D6
Nibbs, R. J. B., Wylie, S. M., Pragnell, I. B., & Graham, G. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.19.12495 · Cited by 139
Pease, J. E., Wang, J., Ponath, P. D., & Murphy, P. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.19972 · Cited by 135
Ruckes, T., Saul, D., Snick, J. V., Hermine, O., & Grassmann, R. (2001) · Blood · doi:10.1182/blood.v98.4.1150 · Cited by 134
Williford, J., Ishihara, J., Ishihara, A., Mansurov, A., Hosseinchi, P., Marchell, T. M., Potin, L., Swartz, M. A., & Hubbell, J. A. (2019) · Science Advances · doi:10.1126/sciadv.aay1357 · Cited by 134
Uehara, S., Song, K., Farber, J. M., & Love, P. E. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.134 · Cited by 133
Hasegawa, H., Nomura, T., Kohno, M., Tateishi, N., Suzuki, Y., Maeda, N., Fujisawa, R., Yoshie, O., & Fujita, S. (2000) · Blood · doi:10.1182/blood.v95.1.30 · Cited by 127
Chemokine Receptor CCR6 Expression Level and Liver Metastases in Colorectal Cancer
Ghadjar, P., Coupland, S. E., Na, I., Noutsias, M., Letsch, A., Stroux, A., Bauer, S., Buhr, H. J., Thiel, E., Scheibenbogen, C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.1822 · Cited by 127
CCL28 chemokine: An anchoring point bridging innate and adaptive immunity
Mohan, T., Deng, L., & Wang, B. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.08.012 · Cited by 125
CCR10 and its ligands in regulation of epithelial immunity and diseases
Xiong, N., Fu, Y., Hu, S., Xia, M., & Yang, J. (2012) · Protein & Cell · doi:10.1007/s13238-012-2927-3 · Cited by 124
Liu, C., Yao, Z., Wang, J., Zhang, W., Yang, Y., Zhang, Y., Qu, X., Zhu, Y., Zou, J., Peng, S., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0506-3 · Cited by 122
RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans
Suffee, N., Hlawaty, H., Meddahi‐Pellé, A., Maillard, L., Louedec, L., Haddad, O., Martin, L., Laguillier, C., Richard, B., Oudar, O., et al. (2012) · Angiogenesis · doi:10.1007/s10456-012-9285-x · Cited by 119
Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5
Nishikawa, G., Kawada, K., Nakagawa, J., Toda, K., Ogawa, R., Inamoto, S., Mizuno, R., Itatani, Y., & Sakai, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1508-2 · Cited by 119
Degos, C., Heinemann, M., Barrou, J., Boucherit, N., Lambaudie, É., Savina, A., Gorvel, L., & Olive, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00877 · Cited by 118
Hoelzinger, D. B., Smith, S. E., Mirza, N. N., Dominguez, A. L., Manrique, S. Z., & Lustgarten, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904084 · Cited by 116
Basophils Promote Tumor Rejection via Chemotaxis and Infiltration of CD8+ T Cells
Sektioglu, I. M., Carretero, R., Bulbuc, N., Bald, T., Tüting, T., Rudensky, A. Y., & Hämmerling, G. J. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0993 · Cited by 116
Chen, Y., Shao, Z., Jiang, E., Zhou, X., Wang, L., Wang, H., Luo, X., Chen, Q., Liu, K., & Shang, Z. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29525 · Cited by 116
Wolf, M., Clark‐Lewis, I., Buri, C., Langen, H., Lis, M., & Mazzucchelli, L. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63914-4 · Cited by 114
Sox2 Communicates with Tregs Through CCL1 to Promote the Stemness Property of Breast Cancer Cells
Xu, Y., Dong, X., Qi, P., Ye, Y., Shen, W., Leng, L., Wang, L., Li, X., Luo, X., Chen, Y., et al. (2017) · Stem Cells · doi:10.1002/stem.2720 · Cited by 113
Regulation of chemokine activity by posttranslational modification
Mortier, A., Damme, J. V., & Proost, P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.006 · Cited by 112
Pan, M., Hou, M., Chang, H., & Hung, W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710038200 · Cited by 112
Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
Araujo, J. M., Gomez, A. C., Aguilar, A., Salgado, R., Balko, J. M., Bravo, L., Doimi, F., Bretel, D., Morante, Z., Flores, C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23099-7 · Cited by 108
Zhou, B., Sun, C., Li, N., Shan, W., Lü, H., Guo, L., Guo, E., Xia, M., WENG, D., Li, M., et al. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3442 · Cited by 108
Xie, F., Liu, L.-B., Shang, W.-Q., Chang, K., Meng, Y., Mei, J., Yu, J., Li, D., & Li, M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.029 · Cited by 106
Yang, X., Lu, P., Fujii, C., Nakamoto, Y., Gao, J., Kaneko, S., Murphy, P. M., & Mukaida, N. (2005) · International Journal of Cancer · doi:10.1002/ijc.21596 · Cited by 106
CCL5/CCR5 axis promotes the motility of human oral cancer cells
Chuang, J., Yang, W., Chen, H., Huang, C., Tan, T., Lin, Y., Hsu, C., Fong, Y., & Tang, C. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21783 · Cited by 104
Berenguer, J., Lagerweij, T., Zhao, X. W., Dusoswa, S. A., van der Stoop, P. P. M., Westerman, B. A., de Gooijer, M. C., Zoetemelk, M., Zomer, A., Crommentuijn, M. H. W., et al. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1446660 · Cited by 103
Feng, N., Jaimes, M. C., Lazarus, N. H., Monack, D. M., Zhang, C., Butcher, E. C., & Greenberg, H. B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.5749 · Cited by 102
Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells
Kochetkova, M., Kumar, S., & McColl, S. R. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2008.190 · Cited by 102
Carramolino, L., Zaballos, Á., Kremer, L., Villares, R., Martı́n, P., Ardavı́n, C., Martínez‐A, C., & Márquez, G. (2001) · Blood · doi:10.1182/blood.v97.4.850 · Cited by 102
Yoshida, R., Nagira, M., Imai, T., Baba, M., Takagi, S., Tabira, Y., Akagi, J., Nomiyama, H., & Yoshie, O. (1998) · International Immunology · doi:10.1093/intimm/10.7.901 · Cited by 100
Dagouassat, M., Suffee, N., Hlawaty, H., Haddad, O., Charni, F., Laguillier, C., Vassy, R., Martin, L., Schischmanoff, P. O., Gattegno, L., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24800 · Cited by 99
Hosoe, N., Miura, S., Watanabe, C., Tsuzuki, Y., Hokari, R., Oyama, T., Fujiyama, Y., Nagata, H., & Ishii, H. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00167.2003 · Cited by 99
Long, H., Xiang, T., Qi, W., Huang, J., Chen, J., He, L., Liang, Z., Guo, B., Li, Y., Xie, R., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3462 · Cited by 98
Functional CCR9 Expression Is Associated with Small Intestinal Metastasis
Letsch, A., Keilholz, U., Schadendorf, D., Assfalg, G., Asemissen, A. M., Thiel, E., & Scheibenbogen, C. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22315.x · Cited by 98
CCL3 promotes angiogenesis by dysregulation of miR-374b/ VEGF-A axis in human osteosarcoma cells
Liao, Y., Tsai, H., Chou, P.-Y., Wang, S., Chen, H., Lin, Y., Chiang, I., Chang, T.-M., Hsu, S.-K., Chou, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6708 · Cited by 97
Wang, B., Shi, L., Sun, X., Wang, L., Wang, X., & Chen, C. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12781 · Cited by 97
I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo
Bernardini, G., Spinetti, G., Ribatti, D., Camarda, G., Morbidelli, L., Ziche, M., Santoni, A., Capogrossi, M. C., & Napolitano, M. (2000) · Blood · doi:10.1182/blood.v96.13.4039 · Cited by 95
Weber, K. S. C., Gröne, H., Röcken, M., Klier, C. M., Gu, S., Wank, R., Proudfoot, A. E. I., Nelson, P. J., & Weber, C. (2001) · European Journal of Immunology · Cited by 94
Expression and Functional Role of CCR9 in Prostate Cancer Cell Migration and Invasion
Singh, S., Singh, U. P., Stiles, J. K., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0266 · Cited by 94
Wang, R., Feng, W., Wang, H., Wang, L., Yang, X. Q., Yang, F., Zhang, Y., Liu, X., Zhang, D., Ren, Q., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.032 · Cited by 94
Azzaoui, I., Yahia, S. A., Chang, Y., Vorng, H., Moralès, O., Fan, Y., Delhem, N., Plé, C., Tonnel, A., Wallaert, B., et al. (2011) · Blood · doi:10.1182/blood-2011-02-338780 · Cited by 93
CCL5 as an adjuvant for cancer immunotherapy
Lapteva, N., & Huang, X. F. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712591003657128 · Cited by 92
Involvement of Chemokine Receptor CCR6 in Colorectal Cancer Metastasis
Rubie, C., Oliveira, V., Kempf, K., Wagner, M., Tilton, B., Rau, B., Kruse, B., nig, J. K. O., & Schilling, M. K. (2006) · Tumor Biology · doi:10.1159/000092777 · Cited by 92
Li, Y., Qiu, X., Zhang, S., Zhang, Q., & Wang, E. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.4.7332 · Cited by 91
Correale, P., Rotundo, M. S., Botta, C., Vecchio, M. T. D., Ginanneschi, C., Licchetta, A., Conca, R., Apollinari, S., Luca, F. D., Tassone, P., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3186 · Cited by 91
CCL1 is a major regulatory T cell attracting factor in human breast cancer
Kühnemuth, B., Piseddu, I., Wiedemann, G. M., Lauseker, M., Kühn, C., Hofmann, S., Schmoeckel, E., Endres, S., Mayr, D. C., Jeschke, U., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-5117-8 · Cited by 91
Goya, Í., Gutiérrez, J., Varona, R., Kremer, L., Zaballos, Á., & Márquez, G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1975 · Cited by 91
Kato, T., Fujita, Y., Nakane, K., Mizutani, K., Terazawa, R., Ehara, H., Kanimoto, Y., Kojima, T., Nozawa, Y., Deguchi, T., et al. (2013) · Cytokine · doi:10.1016/j.cyto.2013.06.313 · Cited by 90
Kimsey, T. F., Campbell, A. S., Albo, D., & Wang, T. N. (2004) · The Cancer Journal · doi:10.1097/00130404-200411000-00007 · Cited by 90
Lavergne, E., Combadière, C., Iga, M., Boissonnas, A., Bonduelle, O., Maho, M., Debré, P., & Combadiere, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3755 · Cited by 89
Iriki, T., Ohnishi, K., Fujiwara, Y., Horlad, H., Saito, Y., Pan, C., Ikeda, K., Mori, T., Suzuki, M., Ichiyasu, H., et al. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.01.003 · Cited by 89
Nandi, B., Shapiro, M., Samur, M., Pai, C., Frank, N. Y., Yoon, C. H., PRABHALA, R. H., Munshi, N. C., & Gold, J. S. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1189052 · Cited by 87
Lien, M.-Y., Tsai, H., Chang, A., Tsai, M.-H., Hua, C.-H., Wang, S., & Tang, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00412 · Cited by 87
Chen, H., Cong, X., Wu, C., Wu, X., Wang, J., Mao, K., Li, J., Zhu, G., Liu, F., Meng, X., et al. (2020) · Science Advances · doi:10.1126/sciadv.aax4690 · Cited by 87
Haque, N. S., Fallon, J. T., Taubman, M. B., & Harpel, P. C. (2001) · Blood · doi:10.1182/blood.v97.1.39 · Cited by 86
CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease
Dairaghi, D. J., Oyajobi, B. O., Gupta, A., McCluskey, B., Miao, S., Powers, J. P., Seitz, L. C., Wang, Y., Zeng, Y., Zhang, P., et al. (2012) · Blood · doi:10.1182/blood-2011-10-384784 · Cited by 86
Chemokine Decoy Receptor D6 Plays a Negative Role in Human Breast Cancer
Wu, F.-Y., Ou, Z.-L., Feng, L.-Y., Luo, J.-M., Wang, L.-P., Shen, Z., & Shao, Z.-M. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2108 · Cited by 86
Cunningham, H., Shannon, L. A., Calloway, P. A., Fassold, B. C., Dunwiddie, I., Vielhauer, G. A., Zhang, M., & Vines, C. (2010) · Translational Oncology · doi:10.1593/tlo.10178 · Cited by 85
Chemokine 25–induced signaling suppresses colon cancer invasion and metastasis
Chen, H. J., Edwards, R. A., Tucci, S., Bu, P., Milsom, J., Lee, S. H., Edelmann, W., Gumus, Z. H., Shen, X., & Lipkin, S. M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62110 · Cited by 85
Lapteva, N., Aldrich, M. B., Weksberg, D. C., Rollins, L. A., Goltsova, T., Chen, S. Y., & Huang, X. F. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318193d31e · Cited by 84
Goya, Í., Gutiérrez, J., Varona, R., Kremer, L., Zaballos, Á., & Márquez, G. (1998) · PubMed · Cited by 83
Mueller, C. G., Boix, C., Kwan, W.-H., Daussy, C., Fournier, E. M., Fridman, W. H., & Molina, T. J. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0706481 · Cited by 83
Snick, J. V., Houssiau, F., Proost, P., Damme, J. V., & Renauld, J. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.6.2570 · Cited by 82
STAT3-RANTES Autocrine Signaling Is Essential for Tamoxifen Resistance in Human Breast Cancer Cells
Yi, E. H., Lee, C. S., Lee, J., Lee, Y. J., Shin, M. K., Cho, C., Kang, K. W., Lee, S. E., Han, W., Noh, D., et al. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0217 · Cited by 82
Sasaki, S., Baba, T., Nishimura, T., Hayakawa, Y., Hashimoto, S., Gotoh, N., & Mukaida, N. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.05.005 · Cited by 82
Sasaki, S., Baba, T., Shinagawa, K., Matsushima, K., & Mukaida, N. (2014) · International Journal of Cancer · doi:10.1002/ijc.28779 · Cited by 80
Takahashi, K., Sivina, M., Hoellenriegel, J., Oki, Y., Hagemeister, F. B., Fayad, L., Romaguera, J. E., Fowler, N. H., Fanale, M. A., Kwak, L. W., et al. (2015) · British Journal of Haematology · doi:10.1111/bjh.13659 · Cited by 79
Lindhout, E., Vissers, J. L. M., Hartgers, F. C., Huijbens, R. J. F., Scharenborg, N. M., Figdor, C. G., & Adema, G. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.3284 · Cited by 79
Atypical chemokine receptors in cancer: friends or foes?
Massara, M., Bonavita, O., Mantovani, A., Locati, M., & Bonecchi, R. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0915-431rr · Cited by 79
Increasing the efficacy of radiotherapy by modulating the CCR2/CCR5 chemokine axes
Connolly, K. A., Belt, B. A., Figueroa, N. M., Murthy, A., Patel, A. P., Kim, M., Lord, E. M., Linehan, D. C., & Gerber, S. A. (2016) · Oncotarget · doi:10.18632/oncotarget.13287 · Cited by 79
CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation
Murooka, T. T., Rahbar, R., & Fish, E. N. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.035 · Cited by 78
Yang, X. L., Liu, K. Y., Lin, F. J., Shi, H. M., & Ou, Z. L. (2017) · Oncology Reports · doi:10.3892/or.2017.5798 · Cited by 78
Thomas, J. K., Mir, H., Kapur, N., Bae, S., & Singh, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-40514-9 · Cited by 78
Liver Metastasis of Cancer Facilitated by Chemokine Receptor CCR6
Dellacasagrande, J., Schreurs, O., Hofgaard, P. O., Omholt, H., Steinsvoll, S., Schenck, K., Bogen, B., & Dembić, Z. (2003) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2003.01263.x · Cited by 77
CCL5 activation of CCR5 regulates cell metabolism to enhance proliferation of breast cancer cells
Gao, D. F., Rahbar, R., & Fish, E. N. (2016) · Open Biology · doi:10.1098/rsob.160122 · Cited by 77
An, G., Wu, F., Huang, S., Lu, F., Bai, J., Gu, S., & Zhao, X. (2019) · Oncology Reports · doi:10.3892/or.2019.7344 · Cited by 77
Swamydas, M., Ricci, K., Rego, S. L., & Dréau, D. (2013) · Cell Adhesion & Migration · doi:10.4161/cam.25138 · Cited by 76
Bergot, A., Ford, N., Leggatt, G. R., Wells, J. W., Frazer, I. H., & Grimbaldeston, M. A. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004466 · Cited by 75
Th22 cell accumulation is associated with colorectal cancer development
Huang, Y., Cao, Y.-F., Jiang, Z.-Y., Zhang, S., & Gao, F. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i14.4216 · Cited by 75
Zhao, N., Dang, H. T., Ma, L., Martin, S. P., Forgues, M., Ylaya, K., Hewitt, S. M., & Wang, X. W. (2020) · Hepatology · doi:10.1002/hep.31412 · Cited by 75
Miyagaki, T., Sugaya, M., Suga, H., Ohmatsu, H., Fujita, H., Asano, Y., Tada, Y., Kadono, T., & Sato, S. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04495.x · Cited by 71
Macrophage inflammatory protein-3α promotes pancreatic cancer cell invasion
Campbell, A. S., Albo, D., Kimsey, T. F., White, S. L., & Wang, T. N. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.07.013 · Cited by 71
Preferential Recruitment of Th17 Cells to Cervical Cancer via CCR6-CCL20 Pathway
Yu, Q., Lou, X., & He, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120855 · Cited by 71
John, A. E., Thomas, M. S., Berlin, A. A., & Lukacs, N. W. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62258-4 · Cited by 71
The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients
Zhang, C., Qi, Y., Li, X., Yang, Y., Liu, D., Zhao, J., Zhu, D., Wu, K., Zhou, X., & Zhao, S. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.12.008 · Cited by 69
Tang, S., Xiang, T., Huang, S., Zhou, J., Wang, Z., Xie, R., Long, H., & Zhu, B. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.034 · Cited by 69
Lin, Z., Li, W., Zhang, H., Wu, W., Peng, Y., Zeng, Y., Wan, Y., Wang, J., & Ouyang, N. (2015) · Tumor Biology · doi:10.1007/s13277-015-4172-x · Cited by 67
Enhanced Expression and Clinical Significance of CC‐Chemokine MIP‐3α in Hepatocellular Carcinoma
Rubie, C., Frick, V. O., Wagner, M., Rau, B., Weber, C., Kruse, B., Kempf, K., Tilton, B., König, J., & Schilling, M. K. (2006) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2006.001766.x · Cited by 67
CCL5 secreted by tumor associated macrophages may be a new target in treatment of gastric cancer
Ding, H., Zhao, L., Dai, S., Li, L., Wang, F., & Shan, B. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.12.004 · Cited by 67
CCR9 and CCL25: A review of their roles in tumor promotion
Xu, B., Deng, C., Wu, X., Ji, T., Zhao, L., Han, Y., Yang, W., Qi, Y., Wang, Z., Yang, Z. P., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29782 · Cited by 65
CCL20/CCR6 expression profile in pancreatic cancer
Rubie, C., Frick, V. O., Ghadjar, P., Wagner, M., Grimm, H., Vicinus, B., Justinger, C., Graeber, S. M., & Schilling, M. K. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-45 · Cited by 64
Eruslanov, E. B., Stoffs, T., Kim, W.-J., Daurkin, I., Gilbert, S. M., Su, L., Vieweg, J., Daaka, Y., & Kusmartsev, S. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2091 · Cited by 64
Vandyke, K., Zeissig, M. N., Hewett, D. R., Martin, S. K., Mrozik, K. M., Cheong, C. M., Diamond, P., To, L. B., Gronthos, S., Peet, D. J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0115 · Cited by 64
Huang, G., Tao, L., Shen, S., & Chen, L. (2016) · Scientific Reports · doi:10.1038/srep27152 · Cited by 63
Cited by
Korbecki, J., Kojder, K., Simińska, D., Bohatyrewicz, R., Gutowska, I., Chlubek, D., & Baranowska-Bosiacka, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218412 · Cited by 465
Self-citationMacrophage Polarity and Disease Control
Kadomoto, S., Izumi, K., & Mizokami, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010144 · Cited by 318
Kidani, Y., Nogami, W., Yasumizu, Y., Kawashima, A., Tanaka, A., Sonoda, Y., Tona, Y., Nashiki, K., Matsumoto, R., Hagiwara, M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2114282119 · Cited by 212
Zhao, F., He, Y., Zhao, Z., He, J., Huang, H., Ai, K., Liu, L., & Cai, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1272133 · Cited by 42
Metadata
- Authors
- Korbecki, J., Grochans, S., Gutowska, I., Barczak, K., & Baranowska-Bosiacka, I.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-10-15
- Volume
- 21
- Issue
- 20
- Pages
- 7619
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3093270998
- Cited by
- 373
- References
- 299
- FWCI
- 15.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.